naturecancer.bsky.social - Profile | ThreadSky | a Reddit-style client for Bluesky

📢Check out this Research Article by Jens Kleesiek, Martin Schuler, Frederick Klauschen and colleagues @naturecancer.bsky.social 'Decoding #pancancer treatment outcomes using #multimodal real-world data and explainable #artificialintelligence' 🔗 www.nature.com/articles/s43...

submitted 14 days ago • 0 comments

Very happy to share this „viewpoint“ article which was just published in @naturecancer.bsky.social , www.nature.com/articles/s43...

submitted 27 days ago • 1 comment

One of the great things about being a #scientist is experiencing research 🧪- and life - in different countries! Thanks to @naturecancer.bsky.social for this interview, where we talked about thriving in diverse ecosystems, supporting young cancer researchers and more! www.nature.com/articles/s43...

submitted 24 days ago • 0 comments

🎂Our 5-YEAR ANNIVERSARY Issue is now ONLINE! @NatureCancer Find it here: www.nature.com/natcancer/vo... Features: ⭐️Reviews and opinion pieces ⭐️Research articles on key developments in #cancerresearch and #oncology

submitted 27 days ago • 0 comments

🌟Check out new online content: study from Daniel Dauch's lab: doi.org/10.1038/s430...

submitted 41 days ago • 0 comments

Reach out to our editor Julieta Alfonso at @keystonesymposia.bsky.social from next Saturday 18th January "Neural Influence on Cancer, Tumor Microenvironment and Cancer Immunology"

submitted 41 days ago • 0 comments

🚨Don't miss The #HTAN live webinar later today! 🔗 workcast.com/register?cpa... With HTAN leaders: Li Ding, Ken Lau, Shannon Hughes and Michael Snyder Chaired by: Alexia-Ileana Zaromytidou (Chief Editor, Nature Cancer) Produced by: Nature/Nature Portfolio

submitted 44 days ago • 0 comments

💫New Article Ongoing replication stress pathways and T cell clonal responses differentiate liver and lung recurrence and are associated with different clinical outcomes in PDAC. ✏️by Jason Link & Rosalie Sears and team www.nature.com/articles/s43...

submitted 47 days ago • 0 comments

💫New Article Dhruva Biswas, Nicolai J. Birkbak & @charlesswanton.bsky.social and team present a clonal expression signature, ORACLE, which, in combination with clinicopathological and molecular risk factors, can predict survival of patients with lung adenocarcinoma. www.nature.com/articles/s43...

submitted 47 days ago • 0 comments

💫Now Online @drchoueiri.bsky.social, David A. Braun & Sachet A. Shukla and teams profiled exceptional responders to immunotherapy in renal cell carcinoma; such responses could be related to tertiary lymphoid structures, clonal neoantigen load and altered metabolism. www.nature.com/articles/s43...

submitted 47 days ago • 0 comments

Now online - Article "Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1–HER3 signaling" ✏️by Roberto Würth & Andreas Trumpp and team 🔗https://www.nature.com/articles/s43018-024-00882-2?utm_source=bluesky&utm_medium=social&utm_campaign=natcancer

submitted 49 days ago • 0 comments

💫New Article online at Nature Cancer "Context-dependent effects of CDKN2A and other 9p21 gene losses during the evolution of esophageal cancer" nature.com/articles/s43018-024-00876-0 ✏️Francesca Ciccarelli @ciccarellilab.bsky.social and team

submitted 51 days ago • 1 comment

📒Systematic review NOW ONLINE! 'The global impact of the #COVID19 pandemic on delays and disruptions in #cancercareservices' ✏️ By Richa Shah and co-authors Read it here: 🔗 www.nature.com/articles/s43...

submitted 55 days ago • 0 comments

⭐️If you haven't yet done so, check out our 2024 year-in-review Focus Issue now! 🔗https://nature.com/collections/chiegfhchj Featuring: Editorial on 2024 #cancerresearch highlights #newPIs Viewpoint #AI and #spatialomics in #oncology (CAR-)T cell therapies in cancer *12 Research Highlights

submitted 68 days ago • 0 comments

⭐️As every December don't miss our Year In Review Focus Issue featuring 2024's highlights in #cancerresearch and #oncology.

submitted 70 days ago • 0 comments

What's up #cancersky? Excited to be here! Follow us for the latest on #cancerresearch and #oncology

submitted 70 days ago • 0 comments

📢Check out this Research Article by Jens Kleesiek, Martin Schuler, Frederick Klauschen and colleagues @naturecancer.bsky.social 'Decoding #pancancer treatment outcomes using #multimodal real-world data and explainable #artificialintelligence' 🔗 www.nature.com/articles/s43...

ONLINE NOW! @naturecancer.bsky.social 'Spatially resolved transcriptomics and graph-based #deeplearning improve accuracy of routine #CNStumor #diagnostics' ✏️By Dieter Henrik Heiland & Felix Sahm and colleagues 🔗 www.nature.com/articles/s43... #spatialtranscriptomics

Very happy to share this „viewpoint“ article which was just published in @naturecancer.bsky.social , www.nature.com/articles/s43...

🎂Our 5-YEAR ANNIVERSARY Issue is now ONLINE! @NatureCancer Find it here: www.nature.com/natcancer/vo... Features: ⭐️Reviews and opinion pieces ⭐️Research articles on key developments in #cancerresearch and #oncology

Online now! TRIM28-dependent developmental heterogeneity determines cancer susceptibility through distinct epigenetic states 🖊️by Ilaria Panzeri & John Andrew Pospisilik and colleagues @ilariapanzeri.bsky.social @andrewpospisilik.bsky.social 👇 www.nature.com/articles/s43...

Online now at Nature Cancer! @maria-sibilia.bsky.social and team propose a strategy to boost immunotherapy by combining topically applied TLR7/8 agonists with systemic interferon-I, sensitizing dendritic cells to produce IL-12 for tumor clearance 👇 www.nature.com/articles/s43...

Online now! Sharon Cantor and team report that increased DNA end resection in BRCA-deficient, PARP inhibitor-resistant cancers leads to increased sensitivity to DNA nicks, limiting tumor formation in mice, and propose the therapeutic exploration of nickases 👇 www.nature.com/articles/s43...

Online now! Puigserver and team show that genetic targeting of specific mitochondrial respiratory complex I subunits in melanoma and breast cancer cells boosts tumor immune surveillance via upregulation of antigen-processing and presentation components. 👇 www.nature.com/articles/s43...

🌟Check out new online content: study from Daniel Dauch's lab: doi.org/10.1038/s430...

Reach out to our editor Julieta Alfonso at @keystonesymposia.bsky.social from next Saturday 18th January "Neural Influence on Cancer, Tumor Microenvironment and Cancer Immunology"

🚨Don't miss The #HTAN live webinar later today! 🔗 workcast.com/register?cpa... With HTAN leaders: Li Ding, Ken Lau, Shannon Hughes and Michael Snyder Chaired by: Alexia-Ileana Zaromytidou (Chief Editor, Nature Cancer) Produced by: Nature/Nature Portfolio

💫New Article Ongoing replication stress pathways and T cell clonal responses differentiate liver and lung recurrence and are associated with different clinical outcomes in PDAC. ✏️by Jason Link & Rosalie Sears and team www.nature.com/articles/s43...

💫New Article Dhruva Biswas, Nicolai J. Birkbak & @charlesswanton.bsky.social and team present a clonal expression signature, ORACLE, which, in combination with clinicopathological and molecular risk factors, can predict survival of patients with lung adenocarcinoma. www.nature.com/articles/s43...

💫Now Online @drchoueiri.bsky.social, David A. Braun & Sachet A. Shukla and teams profiled exceptional responders to immunotherapy in renal cell carcinoma; such responses could be related to tertiary lymphoid structures, clonal neoantigen load and altered metabolism. www.nature.com/articles/s43...

Now online - Article "Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1–HER3 signaling" ✏️by Roberto Würth & Andreas Trumpp and team 🔗https://www.nature.com/articles/s43018-024-00882-2?utm_source=bluesky&utm_medium=social&utm_campaign=natcancer

💫New Article online at Nature Cancer "Context-dependent effects of CDKN2A and other 9p21 gene losses during the evolution of esophageal cancer" nature.com/articles/s43018-024-00876-0 ✏️Francesca Ciccarelli @ciccarellilab.bsky.social and team

📒Systematic review NOW ONLINE! 'The global impact of the #COVID19 pandemic on delays and disruptions in #cancercareservices' ✏️ By Richa Shah and co-authors Read it here: 🔗 www.nature.com/articles/s43...

⭐️If you haven't yet done so, check out our 2024 year-in-review Focus Issue now! 🔗https://nature.com/collections/chiegfhchj Featuring: Editorial on 2024 #cancerresearch highlights #newPIs Viewpoint #AI and #spatialomics in #oncology (CAR-)T cell therapies in cancer *12 Research Highlights

⭐️As every December don't miss our Year In Review Focus Issue featuring 2024's highlights in #cancerresearch and #oncology.

What's up #cancersky? Excited to be here! Follow us for the latest on #cancerresearch and #oncology